Nestl? Health Science S.A. and Nestl? Institute of Health Sciences established to target new opportunity between food and pharma
Nestl? today announced the creation of Nestl? Health Science S.A. and the Nestl? Institute of Health Sciences to pioneer a new industry between food and pharma. These two separate organisations will allow Nestl? to develop the innovative area of personalised health science nutrition to prevent and treat health conditions such as diabetes, obesity, cardiovascular disease and Alzheimer?s disease, which are placing an unsustainable burden on the world?s healthcare systems.
Nestl? Health Science S.A
The Nestl? Institute of Health Sciences
Nestl? Chairman Peter Brabeck-Letmathe said that Nestl? will be a pioneer in helping to shape the space between the food and pharma industry. ?The combination of health economics, changing demographics and advances in health science show that our existing healthcare systems, which focus on treating sick people, are not sustainable and need redesigning. Nestl? has the expertise, the science, the resources and the organisation to play a major role in seeking alternative solutions. Personalised health science nutrition is about finding efficient and cost effective ways to prevent and treat acute and chronic diseases in the 21st century,? he said.
Nestl? CEO Paul Bulcke said: ?The creation of Nestl? Health Science S.A. and the Nestl? Institute of Health Sciences is the best way to focus our attention and organize our unique capabilities and competencies to seize this promising business opportunity. The new set-up will give us a pioneering and leading role in this entirely new industry, while at the same time allowing us to keep the necessary focus on Nestl??s extremely important food, beverages and nutrition business, as embodied by our binding promise of Good Food, Good Life.?
Luis Cantarell, Nestl? Health Science President and CEO designate, said: ?This is an exciting new business opportunity, the execution of which will have a positive long-term impact on peoples? lives. Personalised health science nutrition will create shared value, both for Nestl? and for society, by successfully preventing, improving and treating acute and chronic medical conditions. I am looking forward to getting this ground-breaking work underway.?
Emmanuel E. Baetge, designated head of the Nestl? Institute of Health Sciences, said: ?The Institute will create and deliver world class excellence in biomedical research to better understand human diseases and ageing as influenced by genetics, metabolism and environment. Translating this knowledge will allow us to advance the concept of daily personalised health science nutrition as the most important first step in disease prevention and treatment.?
Nestl?, the world?s leading nutrition, health and wellness company, first entered healthcare nutrition in 1986. Over the last three years, it has made a number of strategic acquisitions in this area such as Novartis Medical Nutrition and Vitaflo. Nestl? HealthCare Nutrition, currently an integral part of Nestl? Nutrition, has a long established reputation as a science-based organisation and has also been setting the trend for personalised nutrition and related services in recent years.
The press conference on this announcement will be webcast live today at 11 am CET on www.nestle.com
Media: Robin Tickle Tel.: +41 21 924 22 00
Investors: Roddy Child-Villiers Tel.: +41 21 924 36 22